Weiss Ratings Reaffirms Hold (C-) Rating for Cooper Companies (NASDAQ:COO)

Key Points

• Weiss Ratings has reaffirmed a Hold (C-) rating for Cooper Companies (NASDAQ: COO), indicating that analysts see the stock as neither a strong buy nor a strong sell.
• Cooper Companies has implemented a $2 billion share buyback program, reflecting the board's belief that the stock is undervalued.
• As of now, the average target price for Cooper Companies is $84.77, with various analysts providing mixed ratings ranging from strong buy to sell.

Cooper Companies (NASDAQ:COO - Get Free Report)'s stock had its "hold (c-)" rating restated by research analysts at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports.

Several other research analysts have also commented on COO. Barclays started coverage on shares of Cooper Companies in a report on Monday, October 13th. They issued an "overweight" rating and a $85.00 price target on the stock. Needham & Company LLC reissued a "buy" rating and issued a $94.00 price objective on shares of Cooper Companies in a research report on Thursday, August 28th. Piper Sandler cut their price objective on Cooper Companies from $105.00 to $83.00 and set an "overweight" rating on the stock in a research report on Thursday, August 28th. Wells Fargo & Company cut their price objective on Cooper Companies from $93.00 to $72.00 and set an "overweight" rating on the stock in a research report on Thursday, August 28th. Finally, Morgan Stanley set a $76.00 target price on Cooper Companies and gave the company an "equal weight" rating in a report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Cooper Companies has an average rating of "Moderate Buy" and an average target price of $84.77.

Cooper Companies Trading Down 1.4%

Shares of COO traded down $1.01 during trading hours on Friday, hitting $73.51. The stock had a trading volume of 1,772,820 shares, compared to its average volume of 2,731,708. The company's fifty day simple moving average is $69.67 and its 200 day simple moving average is $73.24. The firm has a market cap of $14.61 billion, a P/E ratio of 36.21, a P/E/G ratio of 1.96 and a beta of 1.02. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. Cooper Companies has a 12-month low of $61.78 and a 12-month high of $108.32.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period last year, the business posted $0.96 EPS. The company's quarterly revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities research analysts forecast that Cooper Companies will post 3.98 EPS for the current fiscal year.

Cooper Companies announced that its Board of Directors has initiated a share buyback program on Wednesday, September 17th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the medical device company to purchase up to 15.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board believes its shares are undervalued.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, Director Lawrence Erik Kurzius acquired 2,000 shares of the company's stock in a transaction on Monday, September 29th. The shares were bought at an average cost of $68.39 per share, for a total transaction of $136,780.00. Following the acquisition, the director directly owned 5,777 shares of the company's stock, valued at $395,089.03. This trade represents a 52.95% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Albert G. White III acquired 10,000 shares of the company's stock in a transaction on Friday, September 5th. The shares were acquired at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the completion of the acquisition, the chief executive officer directly owned 226,151 shares in the company, valued at $15,466,466.89. The trade was a 4.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders bought 17,975 shares of company stock valued at $1,216,346. Company insiders own 1.98% of the company's stock.

Institutional Investors Weigh In On Cooper Companies

Hedge funds and other institutional investors have recently modified their holdings of the stock. Zions Bancorporation National Association UT bought a new stake in shares of Cooper Companies in the 1st quarter worth about $33,000. J.Safra Asset Management Corp increased its holdings in Cooper Companies by 204.8% in the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company's stock valued at $36,000 after buying an additional 340 shares during the last quarter. CYBER HORNET ETFs LLC bought a new stake in Cooper Companies in the second quarter valued at about $36,000. GKV Capital Management Co. Inc. bought a new stake in Cooper Companies in the first quarter valued at about $40,000. Finally, MUFG Securities EMEA plc bought a new stake in Cooper Companies in the second quarter valued at about $42,000. Institutional investors own 24.39% of the company's stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.